A woman awarded $35 million after suffering severe injuries from Johnson & Johnson’s Prolift transvaginal mesh is ‘satisfied’ by a federal judge’s revised verdict of $20 million, her attorney told DrugWatch.
Barbara Kaiser was awarded $10 million in compensatory damages and $25 million in punitive damages by an Indiana federal jury following a more than one-week-long trial on March 8, 2018.
U.S. District Judge Philip P. Simon later cut the $25 million punitive damages awarded by an Indiana federal jury to $10 million.
Simon of the U.S. District Court for the Northern District of Indiana ruled that the jury erred in its setting of the amount of punitive damages.
Punitive damages are used to punish the wrongdoer or deter them from future wrongdoing. But Simon said the jury improperly decided the amount based on a percentage of J&J’s total net worth ($70 billion) rather than the company’s profits on the Prolift device specific to its Indiana sales of $150,000.
In other words, the $25 million awarded in punitive damages to Kaiser was 166 times the relevant profits earned by J&J and Ethicon on its Prolift mesh sold in a single state.
The judge ruled instead that the award be set at $10 million, giving Kaiser a sum of $20 million in total damages.
An attorney for Kaiser, Thomas O. Plouff, said Simon acted within his discretion in reducing the punitive damages.
“We believe the $25 million in punitive damages awarded by the jury would be more of a deterrent to a $70 billion company knowingly selling a dangerous and harmful medical device,” Plouff said. But he continued, “Given that Simon decided the jury properly awarded $10 million in compensatory damages… we decided it best to accept the remittitur.”
Remittitur is a legal term that simply means a ruling by a judge that lowers an excessive verdict – or amount of damages granted by a jury in a civil case.
“We are satisfied with the final judgment,” Plouff concluded.
Kaiser was one of thousands of injured women who sued J&J and its subsidiary Ethicon over its transvaginal mesh implant sold under the brand name Prolift. She suffered from severe pain in the vaginal area and permanent injury that required corrective surgery after her doctor implanted her with the mesh device.
The jury returned the $35 million verdict after it decided that J&J and Ethicon manufactured a defective product and then failed to adequately warn patients and doctors about its risks.
Thousands of mesh lawsuits filed by injured women across the U.S. are still pending against J&J and Ethicon.
Drugwatch.com writers follow rigorous sourcing guidelines and cite only trustworthy sources of information, including peer-reviewed journals, court records, academic organizations, highly regarded nonprofit organizations, government reports and interviews with qualified experts. Review our editorial policy to learn more about our process for producing accurate, current and balanced content.
Calling this number connects you with one of Drugwatch's trusted legal partners. A law firm representative will review your case for free.
Drugwatch's sponsors support the organization’s mission to keep people safe from dangerous drugs and medical devices. For more information, visit our sponsors page.(888) 645-1617